OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
Lena Marquard, Lise Mette Rahbek Gjerdrum, Ib Jarle Christensen, et al.
Histopathology (2008), pp. ???-???
Open Access | Times Cited: 28
Lena Marquard, Lise Mette Rahbek Gjerdrum, Ib Jarle Christensen, et al.
Histopathology (2008), pp. ???-???
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li, Edward Seto
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 6, Iss. 10, pp. a026831-a026831
Open Access | Times Cited: 1024
Yixuan Li, Edward Seto
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 6, Iss. 10, pp. a026831-a026831
Open Access | Times Cited: 1024
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
Sridurga Mithraprabhu, Anna Kalff, Annie Chow, et al.
Epigenetics (2014) Vol. 9, Iss. 11, pp. 1511-1520
Open Access | Times Cited: 164
Sridurga Mithraprabhu, Anna Kalff, Annie Chow, et al.
Epigenetics (2014) Vol. 9, Iss. 11, pp. 1511-1520
Open Access | Times Cited: 164
Epigenomic regulation of oncogenesis by chromatin remodeling
Rakesh Kumar, D-Q Li, Susanne Müller, et al.
Oncogene (2016) Vol. 35, Iss. 34, pp. 4423-4436
Open Access | Times Cited: 103
Rakesh Kumar, D-Q Li, Susanne Müller, et al.
Oncogene (2016) Vol. 35, Iss. 34, pp. 4423-4436
Open Access | Times Cited: 103
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
Cancer Discovery (2016) Vol. 6, Iss. 9, pp. 986-1005
Open Access | Times Cited: 87
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
Cancer Discovery (2016) Vol. 6, Iss. 9, pp. 986-1005
Open Access | Times Cited: 87
Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma
Li-Si Zeng, Xian-Zi Yang, Yue-Feng Wen, et al.
Aging (2016) Vol. 8, Iss. 6, pp. 1236-1248
Open Access | Times Cited: 71
Li-Si Zeng, Xian-Zi Yang, Yue-Feng Wen, et al.
Aging (2016) Vol. 8, Iss. 6, pp. 1236-1248
Open Access | Times Cited: 71
The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
Maria Cosenza, Samantha Pozzi
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2337-2337
Open Access | Times Cited: 71
Maria Cosenza, Samantha Pozzi
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2337-2337
Open Access | Times Cited: 71
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results
Shinya Rai, Won Seog Kim, Kiyoshi Ando, et al.
Haematologica (2022) Vol. 108, Iss. 3, pp. 811-821
Open Access | Times Cited: 31
Shinya Rai, Won Seog Kim, Kiyoshi Ando, et al.
Haematologica (2022) Vol. 108, Iss. 3, pp. 811-821
Open Access | Times Cited: 31
Recent advancement of HDAC inhibitors against breast cancer
Syed Abdulla Mehmood, Kantrol Kumar Sahu, Sounok Sengupta, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 17
Syed Abdulla Mehmood, Kantrol Kumar Sahu, Sounok Sengupta, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 17
H3K27 Methylation
Jessica N. Nichol, Daphne Dupéré-Richér, Teresa Ezponda, et al.
Advances in cancer research (2016), pp. 59-95
Open Access | Times Cited: 56
Jessica N. Nichol, Daphne Dupéré-Richér, Teresa Ezponda, et al.
Advances in cancer research (2016), pp. 59-95
Open Access | Times Cited: 56
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
Shaji Kumar, Nidhi Tandon, Vijay Ramakrishnan
Clinical Pharmacology Advances and Applications (2016), pp. 35-35
Open Access | Times Cited: 53
Shaji Kumar, Nidhi Tandon, Vijay Ramakrishnan
Clinical Pharmacology Advances and Applications (2016), pp. 35-35
Open Access | Times Cited: 53
Role of Natural Products in Modulating Histone Deacetylases in Cancer
Myriam Mérarchi, Gautam Sethi, Muthu K. Shanmugam, et al.
Molecules (2019) Vol. 24, Iss. 6, pp. 1047-1047
Open Access | Times Cited: 52
Myriam Mérarchi, Gautam Sethi, Muthu K. Shanmugam, et al.
Molecules (2019) Vol. 24, Iss. 6, pp. 1047-1047
Open Access | Times Cited: 52
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine
Maria Cosenza, Monica Civallero, Luigi Marcheselli, et al.
APOPTOSIS (2017) Vol. 22, Iss. 6, pp. 827-840
Open Access | Times Cited: 50
Maria Cosenza, Monica Civallero, Luigi Marcheselli, et al.
APOPTOSIS (2017) Vol. 22, Iss. 6, pp. 827-840
Open Access | Times Cited: 50
Novel therapeutic agents for cutaneous T-Cell lymphoma
Salvia Jain, Jasmine Zain, Owen A. O’Connor
Journal of Hematology & Oncology (2012) Vol. 5, Iss. 1
Open Access | Times Cited: 50
Salvia Jain, Jasmine Zain, Owen A. O’Connor
Journal of Hematology & Oncology (2012) Vol. 5, Iss. 1
Open Access | Times Cited: 50
Histone deacetylase (HDAC)-1, −2, −4 and −6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival
Constantinos Giaginis, Christos Damaskos, Ioannis Koutsounas, et al.
BMC Gastroenterology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 49
Constantinos Giaginis, Christos Damaskos, Ioannis Koutsounas, et al.
BMC Gastroenterology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 49
Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
Linda Anna Michelle Kulka, Pia-Victoria Fangmann, Diana Panfilova, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 36
Linda Anna Michelle Kulka, Pia-Victoria Fangmann, Diana Panfilova, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 36
Epigenetic Aberrations in Multiple Myeloma
Cinzia Caprio, Antonio Sacco, Viviana Giustini, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2996-2996
Open Access | Times Cited: 33
Cinzia Caprio, Antonio Sacco, Viviana Giustini, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2996-2996
Open Access | Times Cited: 33
Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance
Sung Hak Lee, Changyoung Yoo, Soyoung Im, et al.
International Journal of Medical Sciences (2014) Vol. 11, Iss. 10, pp. 994-1000
Open Access | Times Cited: 30
Sung Hak Lee, Changyoung Yoo, Soyoung Im, et al.
International Journal of Medical Sciences (2014) Vol. 11, Iss. 10, pp. 994-1000
Open Access | Times Cited: 30
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1672-1672
Open Access | Times Cited: 15
Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1672-1672
Open Access | Times Cited: 15
Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer
Cynthia Tchio, Adriana Harbuzariu, Ruben R. Gonzalez‐Perez
World Journal of Clinical Oncology (2017) Vol. 8, Iss. 3, pp. 178-178
Open Access | Times Cited: 28
Cynthia Tchio, Adriana Harbuzariu, Ruben R. Gonzalez‐Perez
World Journal of Clinical Oncology (2017) Vol. 8, Iss. 3, pp. 178-178
Open Access | Times Cited: 28
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination
Maria Cosenza, Monica Civallero, Luigi Marcheselli, et al.
APOPTOSIS (2020) Vol. 25, Iss. 5-6, pp. 370-387
Open Access | Times Cited: 20
Maria Cosenza, Monica Civallero, Luigi Marcheselli, et al.
APOPTOSIS (2020) Vol. 25, Iss. 5-6, pp. 370-387
Open Access | Times Cited: 20
Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T‑cell lymphoma
Huilai Zhang, Huijuan Lv, Xiaohui Jia, et al.
Oncology Letters (2019)
Open Access | Times Cited: 19
Huilai Zhang, Huijuan Lv, Xiaohui Jia, et al.
Oncology Letters (2019)
Open Access | Times Cited: 19
Comparison of DNA demethylating and histone deacetylase inhibitors hydralazine-valproate versus vorinostat-decitabine incutaneous t-cell lymphoma in HUT78 cells.
Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, Alfonso Dueñas‐González
PubMed (2018) Vol. 8, Iss. 2, pp. 5-16
Closed Access | Times Cited: 16
Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, Alfonso Dueñas‐González
PubMed (2018) Vol. 8, Iss. 2, pp. 5-16
Closed Access | Times Cited: 16
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
Nishitha Reddy, Andrew Bodiford, Megan Bodge, et al.
OncoTargets and Therapy (2014), pp. 1971-1971
Open Access | Times Cited: 15
Nishitha Reddy, Andrew Bodiford, Megan Bodge, et al.
OncoTargets and Therapy (2014), pp. 1971-1971
Open Access | Times Cited: 15
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma
Markus V. Heppt, Anja Wessely, Eva Hornig, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 849-849
Open Access | Times Cited: 8
Markus V. Heppt, Anja Wessely, Eva Hornig, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 849-849
Open Access | Times Cited: 8
Selective inhibition of HDAC6 sensitizes cutaneous T‑cell lymphoma to PI3K inhibitors
Małgorzata Bobrowicz, Aleksander Ślusarczyk, J Domagała, et al.
Oncology Letters (2020) Vol. 20, Iss. 1, pp. 533-540
Open Access | Times Cited: 8
Małgorzata Bobrowicz, Aleksander Ślusarczyk, J Domagała, et al.
Oncology Letters (2020) Vol. 20, Iss. 1, pp. 533-540
Open Access | Times Cited: 8
